Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Silverback Therapeutics Inc (NQ: SBTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Nov 8, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Silverback Therapeutics Inc < Previous 1 2 3 4 5 Next > ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors February 23, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis February 22, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023 February 09, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis November 10, 2022 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Closes Merger with Silverback Therapeutics November 08, 2022 From Silverback Therapeutics, Inc. Via GlobeNewswire Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis October 21, 2022 From Silverback Therapeutics, Inc. Via Business Wire SILVERBACK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX October 14, 2022 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silverback Therapeutics, Inc. (Nasdaq - SBTX), One Medical (Nasdaq - ONEM), Hanger, Inc. (NYSE - HNGR), VMware, Inc. (NYSE - VMW) July 26, 2022 From Brodsky & Smith LLC Via GlobeNewswire SILVERBACK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX July 22, 2022 From Kahn Swick & Foti, LLC Via Business Wire SBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to Shareholders July 21, 2022 From Halper Sadeh LLP Via Business Wire Silverback Therapeutics and ARS Pharmaceuticals Announce Merger July 21, 2022 From Silverback Therapeutics, Inc. Via Business Wire Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference May 17, 2022 From Silverback Therapeutics, Inc. Via Business Wire Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update May 12, 2022 From Silverback Therapeutics, Inc. Via Business Wire Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results March 31, 2022 From Silverback Therapeutics, Inc. Via Business Wire NASDAQ:SBTX Investor Notice: Investigation over Possible Securities Laws Violations by Silverback Therapeutics, Inc. March 04, 2022 San Diego, CA -- (SBWIRE) -- 03/04/2022 -- Silverback Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference February 24, 2022 From Silverback Therapeutics, Inc. Via Business Wire Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference February 03, 2022 From Silverback Therapeutics, Inc. Via Business Wire Silverback Therapeutics to Participate in the H.C. Wainwright Bioconnect Conference January 05, 2022 From Silverback Therapeutics Via Business Wire Final Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 04, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal SBTX Final Deadline - Bronstein, Gewirtz & Grossman, LLC Reminds Silverback Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 4, 2022 January 04, 2022 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Silverback Deadline Alert January 03, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Deadline Tomorrow Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 03, 2022 Los Angeles - (NewMediaWire) - January 03, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Silverback Therapeutics,... Via NewMediaWire Topics Lawsuit Exposures Financial Legal SILVERBACK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc. and Encourages Investors to Contact the Firm January 02, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire Deadline Tuesday Notice: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 31, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Silverback Shareholder Notice December 31, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Deadline Tuesday Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 30, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Silverback Shareholder Notice December 29, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Tuesday Deadline Reminder: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 29, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Silverback Shareholder Alert December 28, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire 7-Day Deadline Reminder: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 28, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
